Esmelda Blessings Chirwa

Dr. Esmelda Blessings Chirwa

Salmonella Enterica, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in BioTech
Verified
Journal Article
Open access
PDF file
MAMaria Grazia Aruta
Maria Grazia Aruta
ELElisa Lari
Elisa Lari
DSDaniele De Simone
Daniele De Simone
BSBianca Semplici
Bianca Semplici
CSClaudia Semplici
Claudia Semplici
OCon behalf of the Vacc-iNTS Consortium Collaborators
on behalf of the Vacc-iNTS Consortium Collaborators
Nontyphoidal Salmonella (NTS) is a leading cause of morbidity and mortality caused by enteric pathogens worldwide in both children and adults, and vaccines are not yet available. The measurement of antigen-specific antibodies in the sera of vaccinated or convalescent individuals is crucial to understand the incidence of disease and the immunogenicity of vaccine candidates. A solid and standardized assay used to determine the level of specific anti-antigens IgG is therefore of paramount importance. In this work, we presented the characterization of a customized enzyme-linked immunosorbent assay (ELISA) with continuous readouts and a standardized definition of EU/mL. We assessed various performance parameters: standard curve accuracy, dilutional linearity, intermediate precision, specificity, limits of blanks, and quantification. The simplicity of the assay, its high sensitivity and specificity coupled with its low cost and the use of basic consumables and instruments without the need of high automation makes it suitable for transfer and application to different laboratories, including resource-limiting settings where the disease is endemic. This ELISA is, therefore, fit for purpose to be used for quantification of antibodies against Salmonella Typhimurium and Salmonella Enteritidis O-antigens in human samples, both for vaccine clinical trials and large sero-epidemiological studies.

20 February 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
Esmelda Blessings ChirwaEsmelda Blessings Chirwa
Esmelda Blessings Chirwa
HDHelen Dale
Helen Dale
MGMelita A Gordon
Melita A Gordon
PAPhilip M Ashton
Philip M Ashton
Invasive non-typhoidal Salmonella (iNTS) disease is a clinical condition distinct from Salmonella gastroenteritis. With an overall case fatality rate of 14.5% iNTS remains a major cause of morbidity and mortality, particularly in sub-Saharan Africa. However, the sources of infections that lead to cases of iNTS remain unclear. Broadly, there are two hypotheses as to the source of infections i) transmission from a zoonotic reservoir, similar to other non-typhoidal Salmonelloses or ii) person-to-person transmission. Here we review several recent studies that have asked “what is the source of infections causing invasive non-typhoidal Salmonella disease?”. Two studies reported isolates in the stool of household members of iNTS cases that were very closely related (<3 SNPs) to the iNTS case isolates - this is consistent with the hypothesis of person-to-person transmission, but infection from a common source (e.g. a foodstuff) cannot be excluded. On the other hand, thorough investigations of the domestic environment of iNTS cases and the food pathway found only a single iNTS-associated Enteritidis isolate. Therefore, we recommend that future studies test the hypothesis that iNTS is transmitted between people within the domestic environment. Further studies of food and water pathways are also warranted.

16 December 2022 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
MAMaria Grazia Aruta
Maria Grazia Aruta
DSDaniele De Simone
Daniele De Simone
HDHelen Dale
Helen Dale
Esmelda Blessings ChirwaEsmelda Blessings Chirwa
Esmelda Blessings Chirwa
IKInnocent Kadwala
Innocent Kadwala
OCon behalf of the Vacc-iNTS Consortium Collaborators
on behalf of the Vacc-iNTS Consortium Collaborators
Salmonella Typhimurium and Salmonella Enteritidis are leading causative agents of invasive nontyphoidal Salmonella (iNTS) disease, which represents one of the major causes of death and morbidity in sub-Saharan Africa, still partially underestimated. Large sero-epidemiological studies are necessary to unravel the burden of disease and guide the introduction of vaccines that are not yet available. Even if no correlate of protection has been determined so far for iNTS, the evaluation of complement-mediated functionality of antibodies generated towards natural infection or elicited upon vaccination may represent a big step towards this achievement. Here we present the setup and the intra-laboratory characterization in terms of repeatability, intermediate precision, linearity, and specificity of a high-throughput luminescence-based serum bactericidal assay (L-SBA). This method could be useful to perform sero-epidemiological studies across iNTS endemic countries and for evaluation of antibodies raised against iNTS vaccine candidates in upcoming clinical trials.

21 August 2024 in Wellcome Open Research
Verified
Journal Article
Open access
HDHelen Dale
Helen Dale
Esmelda Blessings ChirwaEsmelda Blessings Chirwa
Esmelda Blessings Chirwa
PPPriyanka Patel
Priyanka Patel
GMGeorgina Makuta
Georgina Makuta
FMFelistas Mwakiseghile
Felistas Mwakiseghile
VIVacc- Ints
Vacc- Ints
Background Non-typhoidal Salmonella (NTS) are a major cause of bloodstream infections amongst children in sub-Saharan Africa. A clear understanding of the seroepidemiology and correlates of protection for invasive NTS (iNTS) in relation to key risk factors (malaria, anaemia, malnutrition) in children in Africa is needed to inform strategies for disease control including vaccine implementation. Methodology The SAiNTS study is a prospective community cohort study with paired serology samples from 2500 Malawian children 0–5 years at baseline and three months to measure age-stratified acquisition of lipopolysaccharide (LPS) O-antigen antibody (IgG) and serum bactericidal activity to the main serovars causing iNTS (Salmonella Typhimurium and S. Enteritidis). Children are selected from mapped and censused randomly selected households in Chikwawa, Malawi; an area with substantial malaria burden. The sampling framework is set within a malaria vaccination (RTS,S/ AS01) phase 4 cluster randomized trial, known as the Epidemiology Study of Malaria Transmission Intensity (EPI-MAL), allowing exploration of the impact of malaria vaccination on acquisition of immunity to NTS. Risk factor data for invasive disease will be collected using rapid diagnostic tests for malaria and anaemia, anthropometry for malnutrition, and a validated questionnaire for indicators of socioeconomic status, water and sanitation. All data will be recorded through electronic case report forms using the REDCap and the Open Data Kit (ODK) platforms. Stool sample analysis includes NTS culture and pan-Salmonella polymerase chain reaction to assess enteric exposure and biomarkers of environmental enteric dysfunction. Cases with iNTS disease will be followed up for comparison with community controls. Conclusions The final cohort of 2500 children will allow investigation into the impact of risk factors for iNTS on the acquisition of immunity in children 0–5 years in an endemic setting, including comparisons to partner seroepidemiology studies in three other sub-Saharan African sites (1000 children per site). The data generated will be key to informing iNTS disease control measures including targeted risk factor interventions and vaccine implementation through investigation of correlates of protection and identifying windows of immune susceptibility in at-risk populations.